Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 Standout
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
An Update on the Epidemiology of Inflammatory Bowel Disease in Asia
2008
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
2006 Standout
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Appendicectomy as a Therapy for Ulcerative Proctitis
2009
Smoking and Inflammatory Bowel Disease: A Meta-analysis
2006
Risk factors for inflammatory bowel disease in the general population
2005
Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients
2013
Ulcerative Colitis
2011 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
The risk of developing Crohn’s disease after an appendectomy: a population-based cohort study in Sweden and Denmark
2007
Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases
2010
Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice
2004
Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men
2002
Guidelines for the management of inflammatory bowel disease in adults
2011
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn’s disease
2002
Ulcerative colitis
2002
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Epidemiology and risk factors for IBD
2015 Standout
Appendectomy is followed by increased risk of Crohn's disease
2003
Inflammatory Bowel Disease
2009 Standout
Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review
2008
Non-Alcoholic Fatty Liver Disease in Older People
2009
Inflammatory Bowel Disease and Smoking
2004
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Ulcerative colitis
2012 Standout
Non-alcoholic fatty liver disease
2021 Standout
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
2009
Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials
2006
Crohn's disease
2016 Standout
Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management
2015 Standout
Inflammatory Bowel Disease
2002 Standout
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Review article: remission rates achievable by current therapies for inflammatory bowel disease
2011
Impact of environmental and dietary factors on the course of inflammatory bowel disease
2012
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
A Mouse Model of Accelerated Liver Aging Caused by a Defect in DNA Repair
2011
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
The Risk of Developing Crohn's Disease After an Appendectomy: A Meta-Analysis
2008
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis
2012
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Nonalcoholic Fatty Liver Disease
2007
MEDICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE
1999
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Role of Appendicitis and Appendectomy in the Pathogenesis of Ulcerative Colitis: A Critical Review
2002
Role of genetic and environmental factors in British twins with inflammatory bowel disease
2011
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
The Genetics of Inflammatory Bowel Disease
2007
The Hallmarks of Aging
2013 Standout
Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study
2008
Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study
2012
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Interferon β-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study
2003
Risk factors and characteristics of extent progression in ulcerative colitis
2009
Smoking in inflammatory bowel disease: Impact on disease course and insights into the aetiology of its effect
2014
Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease
2007
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
2010
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?
2006
Effects of appendicectomy on the course of ulcerative colitis
2002
Medical therapy for ulcerative colitis
2000
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study
2002
Passive Smoking and Inflammatory Bowel Disease: A Meta-Analysis
2008
Therapy of inflammatory bowel disease
2000
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Environmental risk factors for inflammatory bowel disease.
2010
Methotrexate for induction of remission in refractory Crohn's disease
2014
Methotrexate for maintenance of remission in ulcerative colitis
2015
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Smoking in inflammatory bowel diseases: Good, bad or ugly?
2007
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Review article: ulcerative colitis, smoking and nicotine therapy
2012
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
2002
Methotrexate for maintenance of remission in Crohn's disease
2014
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
2003 StandoutScience
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
2015
Works of Daniel Keter being referenced
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
1997
Appendectomy is more frequent but not a risk factor in Crohn's disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease
2001
Methotrexate in chronic active ulcerative colitis: A double-blind, randomized, Israeli multicenter trial
1996
Measles is more prevalent in Crohn's disease patients. A multicentre Israeli study
2001
Non‐alcoholic fatty liver disease – a common and benign finding in octogenarian patients
2004
Lack of Association Between Smoking and Crohn's Disease But The Usual Association With Ulcerative Colitis in Jewish Patients in Israel: A Multicenter Study
2000
Effects of Current Cigarette Smoking on Clinical Course of Crohn's Disease and Ulcerative Colitis
2001
Passive smoking in patients with inflammatory bowel disease
2000
Fatty liver-an additional and treatable feature of the insulin resistance syndrome
1999